NeoGenomics (NEO) CEO Chris Smith to retire
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/30/2026
- S&P 500, Nasdaq post best quarter since 2020 despite Iran war
- Dollar pushes higher, yen sinks to 40-year low
- NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
- Citi says bearish flows are building in Nasdaq and S&P 500
- Patrick and LCI Industries to merge in all-stock deal
- Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
- EchoStar Prepares Dish DBS Bankruptcy Filing as Soon as Tuesday - WSJ
- Strategy stock jumps 7% as firm shifts to active capital management
- New leader board: Citi refreshes AI compute semiconductor picks
- Honeywell completes aerospace spin-off, splits into 3 companies
Raymond James Reiterates Market Perform Rating on Neogenomics (NEO) 'in light of the moving parts'
January 10, 2025 1:00 PM ESTRaymond James analyst Andrew Cooper reiterated a Market Perform rating and {REMOVEPT} price target on Neogenomics (NASDAQ: NEO)
The analyst comments "This morning, NeoGenomics announced the retirement of current CEO Chris Smith, naming board member Tony Zook as his successor effective the start of 2Q. The company also reaffirmed its 2024 guidance as part of the release. The retirement is somewhat of a surprise, but comes after a near double move since announcement of Smiths appointment and nearly... More
